Wuhan Hvsen Biotechnology Co Ltd (300871) — Tangible Net Worth Ratio
Wuhan Hvsen Biotechnology Co Ltd (300871) has a Tangible Net Worth Ratio of 95.1% as of June 2026. This metric is calculated by deducting intangible assets (CN¥114.86 Million) from net assets (CN¥2.33 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Wuhan Hvsen Biotechnology Co Ltd (300871) equity growth momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Wuhan Hvsen Biotechnology Co Ltd Tangible Net Worth Ratio (2016–2025)
This chart shows how Wuhan Hvsen Biotechnology Co Ltd's Tangible Net Worth Ratio has changed across 10 annual periods from 2016 to 2025. As of June 2026, the ratio stands at 95.1%, reflecting net assets of CN¥2.33 Billion with intangible assets of CN¥114.86 Million CNY. For live market cap and overall valuation, see Wuhan Hvsen Biotechnology Co Ltd (300871) market capitalisation.
Annual Tangible Net Worth Ratio for Wuhan Hvsen Biotechnology Co Ltd (2016–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Wuhan Hvsen Biotechnology Co Ltd from 2016 to 2025, covering 10 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore capital reinvestment ratio of Wuhan Hvsen Biotechnology Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 94.9% | CN¥2.19 Billion | CN¥110.57 Million | CN¥3.01 Billion | ▲ +2.8 pp |
| 2024 | 92.2% | CN¥1.47 Billion | CN¥114.44 Million | CN¥3.01 Billion | ▼ -0.9 pp |
| 2023 | 93.1% | CN¥1.51 Billion | CN¥104.17 Million | CN¥2.98 Billion | ▲ +0.0 pp |
| 2022 | 93.1% | CN¥1.54 Billion | CN¥106.87 Million | CN¥2.99 Billion | ▼ -0.1 pp |
| 2021 | 93.2% | CN¥1.62 Billion | CN¥110.06 Million | CN¥2.74 Billion | ▲ +0.1 pp |
| 2020 | 93.1% | CN¥1.38 Billion | CN¥95.77 Million | CN¥1.75 Billion | ▲ +19.0 pp |
| 2019 | 74.0% | CN¥378.28 Million | CN¥98.19 Million | CN¥650.08 Million | ▼ -6.4 pp |
| 2018 | 80.4% | CN¥324.52 Million | CN¥63.58 Million | CN¥466.60 Million | ▲ +9.6 pp |
| 2017 | 70.8% | CN¥223.11 Million | CN¥65.07 Million | CN¥344.18 Million | ▼ -10.9 pp |
| 2016 | 81.7% | CN¥154.70 Million | CN¥28.28 Million | CN¥255.86 Million | — |